Stockscreener 앱 받기
9.55
9.14%
0.80
전일 마감가:
$8.75
열려 있는:
$8.75
하루 거래량:
571.42K
Relative Volume:
0.39
시가총액:
$292.94M
수익:
-
순이익/손실:
$-29.25M
주가수익비율:
-8.0523
EPS:
-1.186
순현금흐름:
$-22.80M
1주 성능:
+6.58%
1개월 성능:
+0.84%
6개월 성능:
+109.89%
1년 성능:
+261.06%
1일 변동 폭
$8.695
$9.55
1주일 범위
$8.6234
$9.55
52주 변동 폭
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
명칭
Sagimet Biosciences Inc
전화
(650) 561-8600
주소
155 BOVET RD., SUITE 303, SAN MATEO
SGMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
9.55 | 281.71M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 개시 | Wedbush | Outperform |
| 2025-08-07 | 재개 | H.C. Wainwright | Buy |
| 2025-07-24 | 개시 | Canaccord Genuity | Buy |
| 2024-12-06 | 개시 | Oppenheimer | Outperform |
| 2024-11-12 | 개시 | UBS | Buy |
| 2024-06-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-05-02 | 개시 | H.C. Wainwright | Buy |
| 2024-03-25 | 개시 | Leerink Partners | Outperform |
| 2023-08-08 | 개시 | Goldman | Buy |
| 2023-08-08 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-08 | 개시 | Piper Sandler | Overweight |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
모두보기
Sagimet Biosciences Inc 주식(SGMT)의 최신 뉴스
Sagimet Biosciences Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView
Wedbush Initiates Sagimet Biosciences at Outperform With $28 Price Target - MarketScreener
Wedbush initiates coverage on Sagimet Biosciences stock with Outperform rating - Investing.com Australia
Can Sagimet Biosciences Inc. Escape Recent Bear ChannelDay Trading Signals With High Precision Reviewed - beatles.ru
Sagimet Biosciences SGMT Q2 2025 Earnings Preview Upside Potential Driven by Strategic Innovations - AInvest
Is This a Bottoming Phase for Sagimet Biosciences Inc.Capital Protection Trading Strategies Gain Interest - beatles.ru
Can volume confirm reversal in Sagimet Biosciences Inc.Chart Driven Entry Timing for Swing Trades - Newser
Sagimet Biosciences Inc. Matches Institutional Buying FilterWeekly Chart Analysis With Entry Advice Provided - beatles.ru
How to recover losses in Sagimet Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
How to build a dashboard for Sagimet Biosciences Inc. stockShort-Term Upside Breakout Forecast System - Newser
How sentiment analysis helps forecast Sagimet Biosciences Inc.Market Opportunity Tracker for Swing Traders - Newser
Can Sagimet Biosciences Inc. recover in the next quarterFree Long Hold Safe Return Strategy - Newser
Sagimet Biosciences assumed with a Buy at H.C. Wainwright - TipRanks
Promising Prospects for Sagimet Biosciences: Buy Rating Backed by Innovative FASN Inhibitor Platform and Clinical Advancements - TipRanks
HC Wainwright maintains Buy rating for Sagimet Biosciences with $29 PT. - AInvest
What makes Sagimet Biosciences Inc. stock price move sharplyPre-Market Stock Movement Summary and Review - Newser
Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Clinical-Stage Biotech Sagimet to Share Latest Therapeutic Developments at Major Growth Conference - Stock Titan
Sagimet Biosciences Inc. Testing Reversal Zone on Weekly ChartAlpha Focused Technical Trade Signals Gain Attention - beatles.ru
Is Sagimet Biosciences Inc. a good long term investmentInvest confidently with real-time updates - Jammu Links News
Risk adjusted return profile for Sagimet Biosciences Inc. analyzedMomentum Prediction Based on AI Backtesting - Newser
Is Sagimet Biosciences Inc. stock overvalued or undervaluedMaximize your returns with expert insights - Jammu Links News
What drives Sagimet Biosciences Inc. stock priceCapitalize on momentum-driven investment opportunities - Jammu Links News
Is it the right time to buy Sagimet Biosciences Inc. stockUnstoppable trading performance - Jammu Links News
Should I hold or sell Sagimet Biosciences Inc. stock in 2025Build wealth with high-performing stocks - Jammu Links News
How volatile is Sagimet Biosciences Inc. stock compared to the marketBuild a winning investment strategy - Jammu Links News
How does Sagimet Biosciences Inc. compare to its industry peersBuild wealth faster with consistent investment plans - Jammu Links News
How many analysts rate Sagimet Biosciences Inc. as a “Buy”Build a winning portfolio with smart picks - Jammu Links News
What catalysts could drive Sagimet Biosciences Inc. stock higher in 2025Explosive trading growth - Jammu Links News
What are the technical indicators suggesting about Sagimet Biosciences Inc.Unlock exclusive trading strategies for gains - Jammu Links News
Wyckoff Accumulation Phase Possible in Sagimet Biosciences Inc.Entry Alert Based on Volume Spikes Detected - metal.it
What are the latest earnings results for Sagimet Biosciences Inc.Swing Trade Updates To Watch Now - Jammu Links News
Can Sagimet Biosciences Inc. hit a new high this monthTrade Setups With Clear Risk Limits Highlighted - metal.it
Why Sagimet Biosciences Inc. stock attracts strong analyst attentionEntry Alert With Low Drawdown Strategy Noted - beatles.ru
Sagimet Biosciences Inc. Stock Performance After Earnings: Historical InsightsWeekly Portfolio Update with ROI Focus - Newser
How high can Sagimet Biosciences Inc. stock price go in 2025Daily Stock Forecast Powered by AI Tools - Newser
How Sagimet Biosciences Inc. stock performs during market volatilityCommunity Strategy With High Win Rate Backtested - metal.it
Custom watchlist performance reports with Sagimet Biosciences Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
Sagimet Biosciences Inc. Enters Reversal Setup in Weekly ChartsLow Volatility Stable Growth Picks Rank High - metal.it
Is Sagimet Biosciences Inc. stock reversal real or fakeMulti-Year Signal Summary and Entry Timing - Newser
Chart Patterns Forming a Bullish Setup in Sagimet Biosciences Inc.Investment Plan With Growth Optimization Finalized - metal.it
Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives $26.83 Consensus Target Price from Brokerages - Defense World
Published on: 2025-07-29 07:13:29 - metal.it
How Efficient Is Sagimet Biosciences Inc. at Controlling Operating CostsRisk Limited High Gain Trades - beatles.ru
Sagimet Biosciences Inc. Company Revenue and Profit Trends: A Deep Dive Strategy Playbook for Risk Controlled Trades - Newser
Sagimet Biosciences Inc (SGMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
3.06%
자본화:
|
볼륨(24시간):